Novo Nordisk CEO Lars Fruergaard Jørgensen faced questioning on Capitol Hill over the high cost of the company's weight-loss drugs, Ozempic and Wegovy. Jørgensen claimed the high prices were due to complications of the U.S. healthcare system.
Missouri’s attorney general has a history of opposing efforts to overturn prison convictionsIsrael declares special state of emergency as Hezbollah returns rocket fireSoldier Travis King, who ran into North Korea, pleads guilty to desertionDeaf marathoner set to make history by running in six major racesLebanon doctors describe injuries from device blastsKentucky couple find body believed to be highway shooting suspectFederal reserve cuts interest rates by 0.
5%Hezbollah says handheld devices exploded causing injuries across LebanonEllison Barber describes her interactions with Trump suspect while stationed in UkraineBodycam footage released of officers arresting suspect in Trump assassination attemptNovo Nordisk chief executive Lars Fruergaard Jørgensen faced questioning on Capitol Hill over the health care costs of the company’s weight-loss drugs Ozempic and Wegovy.
Novo Nordisk Ozempic Wegovy Healthcare Costs Drug Prices
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Novo Nordisk CEO to testify at Senate hearing over high weight loss drug pricesSen. Bernie Sanders argues that Novo Nordisk charges Americans substantially higher prices for its drugs than it does for patients in other countries.
Read more »
Novo Nordisk CEO to Face Senate Grilling Over High Drug PricesThe CEO of Novo Nordisk, Lars Fruergaard Jørgensen, will testify before the Senate Health, Education, Labor and Pensions Committee on Tuesday regarding the high prices of the company's weight loss drug Wegovy and diabetes treatment Ozempic. Sen. Bernie Sanders, who chairs the committee, alleges that Novo Nordisk charges significantly higher prices for its drugs in the US compared to other countries.
Read more »
Novo Nordisk CEO testifies at Senate hearing over high weight loss drug pricesSen. Bernie Sanders argues that Novo Nordisk charges Americans substantially higher prices for its drugs than it does for patients in other countries.
Read more »
Ozempic, Wegovy maker Novo Nordisk faces hearing over high cost of weight loss drugsBlockbuster drugs Ozempic and Wegovy have sparked conversation and changed weight loss worldwide. In an exclusive interview, NBC News’ Megan Fitzgerald sits down with Novo Nordisk CEO Lars Fruergaard Jørgensen who helmed it all, and presses him on the high price, drug shortages, and long-term effects.
Read more »
Novo Nordisk's New Weight Loss Drug Shows Ominous Psychiatric Side EffectsScience and Technology News and Videos
Read more »
Novo Nordisk weight-loss drug is effective for kids as young as 6, study showsA drug approved to treat obesity in adults and teens is safe and effective for use in kids as young as 6 when combined with diet and exercise, a small new study…
Read more »